Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
N Engl J Med
    June 2026
  1. ROBOZ GJ, Zeidan AM, Mannis GN, Montesinos P, et al
    All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.
    N Engl J Med. 2026;394:2107-2116.
    >> Share

    May 2026
  2. WARE RE, Opoka RO, Latham T, Kasirye P, et al
    Ten Years of Hydroxyurea for Ugandan Children with Sickle Cell Anemia.
    N Engl J Med. 2026;394:2059-2061.
    >> Share

  3. ZIPERSTEIN JC, Barnawi RA, Al-Samkari H, Bolster MB, et al
    Case 14-2026: A 50-Year-Old Woman with Vaginal Bleeding and Anemia.
    N Engl J Med. 2026;394:1940-1951.
    >> Share

  4. GUPTA AO, Sharma A, Frangoul H, Kanter J, et al
    Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.
    N Engl J Med. 2026;394:1824-1835.
    >> Share

    April 2026
  5. XIONG H, Li R, Shi J
    CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia. Reply.
    N Engl J Med. 2026;394:1455.
    >> Share

  6. YANG S, Lu Y
    CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.
    N Engl J Med. 2026;394:1455.
    >> Share

  7. FRANGOUL H, Hanna R, Walters MC, Kao RL, et al
    CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat beta-Thalassemia.
    N Engl J Med. 2026;394:1292-1301.
    >> Share

  8. HANNA R, Frangoul H, Pineiro L, McKinney C, et al
    CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
    N Engl J Med. 2026;394:1281-1291.
    >> Share

    February 2026
  9. DUMBRAVA EE, Shapiro GI, Parikh AR, Johnson ML, et al
    Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.
    N Engl J Med. 2026;394:872-883.
    >> Share

    January 2026
  10. LI R, Pan H, Zhang L, Ma J, et al
    CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.
    N Engl J Med. 2026;394:253-267.
    >> Share

    November 2025
  11. JIMENEZ C, Andreassen M, Durand A, Moog S, et al
    Belzutifan for Advanced Pheochromocytoma or Paraganglioma.
    N Engl J Med. 2025;393:2012-2022.
    >> Share

    October 2025
  12. SANDS BE, Shenoy-Bhangle AS, Lemieux JE, Johnson PC, et al
    Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia.
    N Engl J Med. 2025;393:1731-1740.
    >> Share

  13. COSTA E, Ware R, Tshilolo L, Luzzatto L, et al
    Thirty Years of Hydroxyurea for Sickle Cell Anemia - Scientific Progress, Global Health Gaps.
    N Engl J Med. 2025;393:1556-1559.
    >> Share

  14. CORTES J, Punie K, Barrios C, Hurvitz SA, et al
    Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.
    N Engl J Med. 2025 Oct 19. doi: 10.1056/NEJMoa2511734.
    >> Share

    June 2025
  15. ZHANG L, Gao Z, Pan H, Li R, et al
    BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy.
    N Engl J Med. 2025;392:2282-2284.
    >> Share

  16. XUE W, Jones DS
    Debating Race and the Diagnosis of Anemia - How Medicine Moved Away from Race-Based Standards.
    N Engl J Med. 2025;392:2168-2173.
    >> Share

    March 2025
  17. ENGLISH SW, Delaney A, Fergusson DA, Chasse M, et al
    Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage.
    N Engl J Med. 2025;392:1079-1088.
    >> Share

    August 2024
  18. WANDER SA, Thai JN, Wirth LJ, Soto DE, et al
    Case 26-2024: A 59-Year-Old Woman with Aphasia, Anemia, and a Breast Mass.
    N Engl J Med. 2024;391:747-757.
    >> Share

  19. TURGEON AF, Fergusson DA, Clayton L, Patton MP, et al
    Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury.
    N Engl J Med. 2024;391:722-735.
    >> Share

  20. ISRAEL A, Raz I, Vinker S, Magen E, et al
    Type 2 Diabetes in Patients with G6PD Deficiency.
    N Engl J Med. 2024;391:568-569.
    >> Share

  21. FRANGOUL H, Hobbs WE, Locatelli F
    Studies of Exagamglogene Autotemcel - Age and Place. Reply.
    N Engl J Med. 2024;391:572.
    >> Share

  22. MIN J
    Studies of Exagamglogene Autotemcel - Age and Place.
    N Engl J Med. 2024;391:571-572.
    >> Share

    June 2024
  23. RISITANO AM, Kulasekararaj AG, Peffault de Latour R
    Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria. Reply.
    N Engl J Med. 2024;390:2033-2034.
    >> Share

  24. MARNAS P, Zarogiannis SG
    Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.
    N Engl J Med. 2024;390:2033.
    >> Share

  25. HILLMEN P
    Oral Iptacopan in Paroxysmal Nocturnal Hemoglobinuria.
    N Engl J Med. 2024;390:2032-2033.
    >> Share

    May 2024
  26. OLSON R, Vaidya A, Aung KK, Merz LE, et al
    Adding Insult to Injury.
    N Engl J Med. 2024;390:e51.
    >> Share

  27. FRANGOUL H, Locatelli F, Sharma A, Bhatia M, et al
    Exagamglogene Autotemcel for Severe Sickle Cell Disease.
    N Engl J Med. 2024;390:1649-1662.
    >> Share

  28. LOCATELLI F, Lang P, Wall D, Meisel R, et al
    Exagamglogene Autotemcel for Transfusion-Dependent beta-Thalassemia.
    N Engl J Med. 2024;390:1663-1676.
    >> Share

  29. DALEY GQ
    Welcoming the Era of Gene Editing in Medicine.
    N Engl J Med. 2024;390:1642-1645.
    >> Share

  30. MCCUNE JM, Kiem HP
    Extending Gene Medicines to All in Need.
    N Engl J Med. 2024;390:1721-1722.
    >> Share

    April 2024
  31. LAM WK, Yip SF
    Drug-Induced Oxidative Hemolysis.
    N Engl J Med. 2024;390:1513.
    >> Share

    March 2024
  32. PEFFAULT DE LATOUR R, Roth A, Kulasekararaj AG, Han B, et al
    Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
    N Engl J Med. 2024;390:994-1008.
    >> Share

  33. CARSON JL, Brooks MM, Hebert PC
    Transfusion Strategy in Myocardial Infarction and Anemia. Reply.
    N Engl J Med. 2024;390:961-962.
    >> Share

  34. KHAN MS, Spertus JA, Chan PS
    Transfusion Strategy in Myocardial Infarction and Anemia.
    N Engl J Med. 2024;390:960-961.
    >> Share

  35. CHAPALAIN X, Aubron C
    Transfusion Strategy in Myocardial Infarction and Anemia.
    N Engl J Med. 2024;390:960.
    >> Share

    December 2023
  36. FREEDMAN SB, van de Kar NCAJ, Tarr PI
    Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome. Reply.
    N Engl J Med. 2023;389:2500.
    >> Share

  37. JACOBS FM
    Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome.
    N Engl J Med. 2023;389:2499-2500.
    >> Share

  38. NORIS M, Remuzzi G
    Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome.
    N Engl J Med. 2023;389:2499.
    >> Share

    November 2023
  39. AZAR SS, Simeone FJ, Jarolimova J, Nussbaum EZ, et al
    Case 37-2023: A 29-Year-Old Man with Sickle Cell Disease and Right Hip Pain.
    N Engl J Med. 2023;389:2088-2096.
    >> Share

  40. CARSON JL, Brooks MM, Hebert PC, Goodman SG, et al
    Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
    N Engl J Med. 2023 Nov 11. doi: 10.1056/NEJMoa2307983.
    >> Share

  41. ZACHRISON KS, Kamalian S, Sykes DB, Brunker PAR, et al
    Case 34-2023: A 49-Year-Old Woman with Loss of Consciousness and Thrombocytopenia.
    N Engl J Med. 2023;389:1804-1811.
    >> Share

    October 2023
  42. FREEDMAN SB, van de Kar NCAJ, Tarr PI
    Shiga Toxin-Producing Escherichia coli and the Hemolytic-Uremic Syndrome.
    N Engl J Med. 2023;389:1402-1414.
    >> Share

    August 2023
  43. SHARMA A, Boelens JJ, Cancio M, Hankins JS, et al
    CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
    N Engl J Med. 2023;389:820-832.
    >> Share

  44. FUKUSHIMA H, Matsumoto M
    Cold Agglutinin Syndrome.
    N Engl J Med. 2023;389:642.
    >> Share

  45. SCHREIBER AR, Santos J, McMahon B, Buckner TW, et al
    A Case of Fetal-Induced Graft-versus-Host Disease.
    N Engl J Med. 2023;389:668-670.
    >> Share

  46. VAN BAARLE FLF, Biemond BJ, Vlaar APJ
    Platelet Transfusion in Patients with Thrombocytopenia. Reply.
    N Engl J Med. 2023;389:480.
    >> Share

  47. GILSTAD CW
    Platelet Transfusion in Patients with Thrombocytopenia.
    N Engl J Med. 2023;389:479-480.
    >> Share

  48. WARNER MA, Hess AS, Frank SM
    Platelet Transfusion in Patients with Thrombocytopenia.
    N Engl J Med. 2023;389:479.
    >> Share

  49. SHIBUSAWA M, Tanimoto T
    Platelet Transfusion in Patients with Thrombocytopenia.
    N Engl J Med. 2023;389:478-479.
    >> Share

    June 2023
  50. BLOCK J, Rashkova C, Castanon I, Zoghi S, et al
    Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency.
    N Engl J Med. 2023 Jun 21. doi: 10.1056/NEJMoa2210054.
    >> Share

    April 2023
  51. VAN DIJCK R, Goncalves Silva AM, Rijneveld AW
    Luspatercept as Potential Treatment for Congenital Sideroblastic Anemia.
    N Engl J Med. 2023;388:1435-1436.
    >> Share

  52. CHILDERHOSE JE, Cronin RM, Klatt MD, Schamess A, et al
    Treating Chronic Pain in Sickle Cell Disease - The Need for a Biopsychosocial Model.
    N Engl J Med. 2023;388:1349-1351.
    >> Share

  53. CHASSE M, Fergusson DA, Tinmouth A, Acker JP, et al
    Effect of Donor Sex on Recipient Mortality in Transfusion.
    N Engl J Med. 2023;388:1386-1395.
    >> Share

    March 2023
  54. BURTSCHER M
    Oxygen Delivery in the Treatment of Anemia.
    N Engl J Med. 2023;388:e38.
    >> Share

  55. LEE AI, Heidari P, Fenves AZ, Bardia A, et al
    Case 8-2023: A 71-Year-Old Woman with Refractory Hemolytic Anemia.
    N Engl J Med. 2023;388:1032-1041.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016